1. Portable electronic vision enhancement systems in comparison with optical magnifiers for near vision activities: an economic evaluation alongside a randomized crossover trial.
- Author
-
Bray, Nathan, Brand, Andrew, Taylor, John, Hoare, Zoe, Dickinson, Christine, and Edwards, Rhiannon T.
- Subjects
VISION disorders ,MAGNIFYING glasses ,RANDOMIZED controlled trials ,CROSSOVER trials ,QUALITY of life ,WELL-being - Abstract
Purpose To determine the incremental cost-effectiveness of portable electronic vision enhancement system (p- EVES) devices compared with optical low vision aids ( LVAs), for improving near vision visual function, quality of life and well-being of people with a visual impairment. Methods An AB/ BA randomized crossover trial design was used. Eighty-two participants completed the study. Participants were current users of optical LVAs who had not tried a p- EVES device before and had a stable visual impairment. The trial intervention was the addition of a p- EVES device to the participant's existing optical LVA(s) for 2 months, and the control intervention was optical LVA use only, for 2 months. Cost-effectiveness and cost-utility analyses were conducted from a societal perspective. Results The mean cost of the p- EVES intervention was £448. Carer costs were £30 (4.46 hr) less for the p- EVES intervention compared with the LVA only control. The mean difference in total costs was £417. Bootstrapping gave an incremental cost-effectiveness ratio (ICER) of £736 (95% CI £481 to £1525) for a 7% improvement in near vision visual function. Cost per quality-adjusted life year ( QALY) ranged from £56 991 (lower 95% CI = £19 801) to £66 490 (lower 95% CI = £23 055). Sensitivity analysis varying the commercial price of the p- EVES device reduced ICERs by up to 75%, with cost per QALYs falling below £30 000. Conclusion Portable electronic vision enhancement system (p- EVES) devices are likely to be a cost-effective use of healthcare resources for improving near vision visual function, but this does not translate into cost-effective improvements in quality of life, capability or well-being. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF